Germline mutations in PTEN are a hallmark of PHTS, including CS [7], where they are believed to drive increased lifetime risk for cancer, and risk for developing certain cancers in childhood, such as thyroid and renal cancer [11]. This evidence concerns the gene PTEN and renal carcinoma.